21,107 Shares in The Clorox Company (NYSE:CLX) Acquired by Strategic Financial Concepts LLC

Strategic Financial Concepts LLC purchased a new stake in shares of The Clorox Company (NYSE:CLXFree Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 21,107 shares of the company’s stock, valued at approximately $3,428,000.

Other institutional investors have also recently bought and sold shares of the company. Leo Wealth LLC raised its holdings in shares of Clorox by 33.0% in the fourth quarter. Leo Wealth LLC now owns 3,514 shares of the company’s stock valued at $571,000 after buying an additional 871 shares during the last quarter. Consolidated Portfolio Review Corp bought a new position in shares of Clorox in the fourth quarter worth about $318,000. Vision Capital Management Inc. acquired a new position in shares of Clorox during the fourth quarter worth approximately $201,000. Money Concepts Capital Corp grew its stake in shares of Clorox by 3.3% during the fourth quarter. Money Concepts Capital Corp now owns 22,056 shares of the company’s stock valued at $3,582,000 after purchasing an additional 697 shares during the last quarter. Finally, Lion Street Advisors LLC increased its holdings in shares of Clorox by 10.0% in the fourth quarter. Lion Street Advisors LLC now owns 5,294 shares of the company’s stock valued at $860,000 after purchasing an additional 480 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.6 %

Shares of NYSE CLX opened at $148.51 on Monday. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The stock has a market cap of $18.38 billion, a price-to-earnings ratio of 40.58, a P/E/G ratio of 2.52 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The company’s fifty day moving average is $161.06 and its 200-day moving average is $158.88.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the firm earned $2.16 EPS. Equities research analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.29%. Clorox’s payout ratio is 133.33%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on CLX shares. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Barclays upped their price target on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Evercore ISI upped their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $158.21.

Check Out Our Latest Research Report on CLX

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.